Literature DB >> 8631312

Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.

C Isel1, J M Lanchy, S F Le Grice, C Ehresmann, B Ehresmann, R Marquet.   

Abstract

Initiation of RNA-dependent DNA synthesis by retroviral reverse transcriptases is generally considered as unspecific. In the case of human immunodeficiency virus type 1 (HIV-1), the natural primer is tRNA3Lys. We recently found evidence of complex interactions between tRNA3Lys and HIV-1 RNA that may be involved in the priming process. In this study, we compare the ability of natural and unmodified synthetic tRNA3Lys and 18mer oligoribo- and oligodeoxyribonucleotides complementary to the viral primer binding site to initiate replication of HIV-1 RNA using either homologous or heterologous reverse transcriptases. We show that HIV-1 RNA, HIV-1 reverse transcriptase and primer tRNA3Lys form a specific initiation complex that differs from the unspecific elongation complex formed when an oligodeoxyribonucleotide is used as primer. Modified nucleosides of tRNA3Lys are required for efficient initiation and transition to elongation. Transition from initiation to elongation, but not initiation of reverse transcription itself, is facilitated by extended primer-template interactions. Elongation, but not initiation of reverse transcription, is inhibited by Mn2+, which further differentiates these two different functional states of reverse transcriptase. These results define initiation of reverse transcription as a target to block viral replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631312      PMCID: PMC450289     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes.

Authors:  B M Wöhrl; B Ehresmann; G Keith; S F Le Grice
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

2.  A specific orientation of RNA secondary structures is required for initiation of reverse transcription.

Authors:  A Aiyar; Z Ge; J Leis
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription.

Authors:  C Isel; R Marquet; G Keith; C Ehresmann; B Ehresmann
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

4.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Human immunodeficiency virus reverse transcriptase. A kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization.

Authors:  J E Reardon
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

6.  Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide.

Authors:  X Zhan; C K Tan; W A Scott; A M Mian; K M Downey; A G So
Journal:  Biochemistry       Date:  1994-02-15       Impact factor: 3.162

7.  On the early emergence of reverse transcription: theoretical basis and experimental evidence.

Authors:  A Lazcano; V Valverde; G Hernández; P Gariglio; G E Fox; J Oró
Journal:  J Mol Evol       Date:  1992-12       Impact factor: 2.395

8.  Mechanism and fidelity of HIV reverse transcriptase.

Authors:  W M Kati; K A Johnson; L F Jerva; K S Anderson
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.

Authors:  E J Arts; X Li; Z Gu; L Kleiman; M A Parniak; M A Wainberg
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

10.  Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.

Authors:  J Mak; M Jiang; M A Wainberg; M L Hammarskjöld; D Rekosh; L Kleiman
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  88 in total

1.  In vitro evidence for the interaction of tRNA(3)(Lys) with U3 during the first strand transfer of HIV-1 reverse transcription.

Authors:  F Brulé; G Bec; G Keith; S F Le Grice; B P Roques; B Ehresmann; C Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  The effect of mutations in the HIV-1 nucleocapsid protein on strand transfer in cell-free reverse transcription reactions.

Authors:  M Hsu; L Rong; H de Rocquigny; B P Roques; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

3.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  NMR structure of the chimeric hybrid duplex r(gcaguggc).r(gcca)d(CTGC) comprising the tRNA-DNA junction formed during initiation of HIV-1 reverse transcription.

Authors:  T Szyperski; M Götte; M Billeter; E Perola; L Cellai; H Heumann; K Wüthrich
Journal:  J Biomol NMR       Date:  1999-04       Impact factor: 2.835

7.  Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent.

Authors:  Mamuka Kvaratskhelia; Jennifer T Miller; Scott R Budihas; Lewis K Pannell; Stuart F J Le Grice
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

8.  The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.

Authors:  C Liang; X Li; L Rong; P Inouye; Y Quan; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

10.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

Authors:  X Wei; M Götte; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.